Inc. (Nasdaq: APLT), a biopharmaceutical company dedicated to creating transformative treatments for rare disease, today announced that the U.S. Food and Drug Administration (FDA) has issued a ...
Rallybio Corporation , a clinical-stage biotechnology company translating scientific advances into transformative therapies for patients with devastating rare diseases, today announced the publication ...
Adverse drug reactions (ADRs) and medication adherence are critical aspects of healthcare, particularly within pediatric and obstetric fields. Pediatric patients and pregnant women are often more ...
The Pacalis team is a blend of industry and academic expertise, led by co-founder and Monash university alumnus Dr David Bibby as Chief Executive Officer, and co-founder Professor Chris Langmead, ...
Rallybio Corporation (NASDAQ: RLYB) shares gained only slightly, as the clinical-stage biotechnology company translating scientific advances into transformative therapies for patients with devastating ...
Prof Dr Vishal R Tandon (Professor of Pharmacology, GMC Jammu) was awarded scroll of prestigious fellowship of NAMS at AIIMS, Jodhpur. The fellowship was awarded to Dr Tandon by Director AIIMS Jodhpur ...